AnodyneWiki

Olanzapine

Olanzapine
Olanzapine
Salts
[]
Olanzapine hydrochloride
Olanzapine hydrochloride
Olanzapine tartrate
Olanzapine tartrate
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass312.40 g/mol [1]
AppearanceYellow crystalline solid [1]
Melting point189-195 °C [1]
Boiling point476 °C [1]
DecompositionWhen heated to decomposition it emits toxic fumes of /nitrogen oxides and sulfur oxides/. [1]
SolubilityPartly miscible [1]
Predicted LogP2.9 [1]
Structural Identifiers
[]
Molecular formulaC17H20N4S
IUPAC name2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine
SMILESCC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C
InChIInChI=1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3
InChIKeyKVWDHTXUZHCGIO-UHFFFAOYSA-N
CAS number132539-06-1
UNIIN7U69T4SZR
PubChem CID135398745
Pharmacokinetics[]
Elimination half-life33 hours, 51.8 hours (elderly)
MetabolismLiver (direct glucuronidation and CYP1A2 mediated oxidation)
ExcretionUrine (57%; 7% as unchanged drug), faeces (30%)
Routes of administrationBy mouth, intramuscular

Olanzapine (also known as Olansek, Zyprexa Zydis, Zalasta, Zyprexa Velotab, olanzapina, Zyprexa Intramuscular, Olanzapine Mylan, Olazax, Ly-170053 or 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine) is a substance of the aniline and thienodiazepine class.

Chemistry

Salts []

Olanzapine is typically found in the form of its hydrochloride and tartrate salts.

 []

Olanzapine is achiral.

Olanzapine matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

The activity of olanzapine is achieved by the antagonism of multiple neuronal receptors including the dopamine receptor D1, D2, D3 and D4 in the brain, the serotonin receptors 5HT2A, 5HT2C, 5HT3 and 5HT6, the alpha-1 adrenergic receptor, the histamine receptor H1 and multiple muscarinic receptors. As abovementioned, olanzapine presents a wide profile of targets, however, its antagonistic effect towards the dopamine D2 receptor in the mesolimbic pathway is key as it blocks dopamine from having a potential action at the post-synaptic receptor. The binding of olanzapine to the dopamine D2 receptors is easily dissociable and hence, it allows for a certain degree of dopamine neurotransmission. On the other hand, olanzapine acts in the serotonin 5HT2A receptors in the frontal cortex in a similar manner than the reported on dopamine D2 receptors. This determined effect allows for a decrease in adverse effects. [1]

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

shared target184
inhibition / metabolism / induction34 (2 contraindicated)
shared target34
shared target34
shared target30
shared target26
shared target24
shared target18
shared target16 (6 contraindicated)
shared target16 (6 contraindicated)
shared target16 (6 contraindicated)

Medical side effects []

434 side effects listed on drug labels in (olanzapine).

  • Somnolence
  • Headache
  • Increased appetite
  • Nervousness
  • Tension
  • Hallucination
  • Lethargy
  • Blood prolactin increased
  • Increased prolactin level
  • Serum prolactin increased
  • Hypersomnia
  • Blood bilirubin decreased
  • Bilirubin total low
  • Hostility
  • Weight increased
  • Injury
  • Intentional injury
  • Parkinsonism
  • Parkinson's disease
  • Insomnia
  • Asthenia
  • Fatigue
  • Pain
  • Anxiety
  • Phobia
  • Constipation
  • Dizziness
  • Syncope
  • Personality disorder
  • Alanine aminotransferase increased
  • Dyspepsia
  • Rhinitis
  • Gamma-glutamyltransferase increased
  • Abdominal pain
  • Gastrointestinal pain
  • Dry mouth
  • Cough
  • Gait disturbance
  • Back pain
  • Conjunctivitis
  • Delusion
  • Dyspnoea
  • Ecchymosis
  • Eosinophilia
  • Body temperature increased
  • Flatulence
  • Orthostatic hypotension
  • Influenza
  • Pain in extremity
  • Paraesthesia
  • Pneumonia
  • Salivary hypersecretion
  • Thirst
  • Toothache
  • Vaginal inflammation
  • Vaginal infection
  • Mood swings
  • Affect lability
  • Mania
  • Injection site pain
  • Schizophreniform disorder
  • Joint stiffness
  • Akathisia
  • Nasopharyngitis
  • Pharyngitis
  • Speech disorder
  • Tremor
  • Vaginal discharge
  • Amblyopia
  • Arthralgia
  • Musculoskeletal discomfort
  • Myalgia
  • Chest pain
  • Diarrhoea
  • Hypertonia
  • Respiratory tract infection
  • Sinusitis
  • Tachycardia
  • Upper respiratory tract infection
  • Agitation
  • Hyperkinesia
  • Hepatic enzyme increased
  • Laryngeal pain
  • Amnesia
  • Phonological disorder
  • Blepharitis
  • Fungal skin infection
  • Oedema
  • Eye disorder
  • Hypertension
  • Hypotension
  • Arthropathy
  • Osteoarthritis
  • Dysarthria
  • Menstrual disorder
  • Nasal congestion
  • Muscle spasms
  • Cramps of lower extremities
  • Generalised spasm
  • Urinary incontinence
  • Urinary tract infection
  • Oedema peripheral
  • Edema of lower extremities
  • Upper limb oedema
  • Musculoskeletal stiffness
  • Nuchal rigidity
  • Rash pustular
  • Dermatitis bullous
  • Aspartate aminotransferase increased
  • Muscle twitching
  • Euphoric mood
  • Acne
  • Drug dependence
  • Dependence psychological
  • Drug seeking behavior
  • Abnormal dreams
  • Neurosis
  • Corneal lesion
  • Abdominal distension
  • Enlargement abdomen
  • Acidosis
  • Alopecia
  • Amenorrhoea
  • Anaemia
  • Apnoea
  • Arthritis
  • Rheumatoid arthritis
  • Asthma
  • Ataxia
  • Atrial fibrillation
  • Atrioventricular block
  • Block heart
  • Candida infection
  • Oral candidiasis
  • Neck pain
  • Confusional state
  • Feeling abnormal
  • Malaise
  • Cyanosis
  • Cystitis
  • Bladder pain
  • Cystitis noninfective
  • Deafness
  • Libido decreased
  • Disturbance in sexual arousal
  • Libido increased
  • Dysphagia
  • Dehydration
  • Delirium
  • Dental caries
  • Depersonalisation
  • Dermatitis contact
  • Diabetes mellitus
  • Diplopia
  • Dysgeusia
  • Dysuria
  • Urination impaired
  • Ear pain
  • Eczema
  • Endophthalmitis
  • Panophthalmitis
  • Epistaxis
  • Oesophagitis
  • Eye haemorrhage
  • VIIth nerve paralysis
  • Faecal incontinence
  • Faecalith
  • Faecaloma
  • Gastritis
  • Gastroenteritis
  • Gingivitis
  • Glycosuria
  • Gynaecomastia
  • Cardiac arrest
  • Cardiac failure congestive
  • Haematuria
  • Haemoptysis
  • Haemorrhage
  • Haemoglobin
  • Hyperbilirubinaemia
  • Hypercholesterolaemia
  • Hyperlipidaemia
  • Hyperventilation
  • Hypoaesthesia
  • Hypoglycaemia
  • Hypokalaemia
  • Hyponatraemia
  • Hypoproteinaemia
  • Laryngitis
  • Leukocytosis
  • Leukopenia
  • Breast pain
  • Melaena
  • Menorrhagia
  • Metrorrhagia
  • Hypotonia
  • Muscle relaxant therapy
  • Nausea
  • Pallor
  • Palpitations
  • Pelvic pain
  • Tooth abscess
  • Polyuria
  • Urine output increased
  • Premenstrual syndrome
  • Pyuria
  • Seborrhoeic dermatitis
  • Skin ulcer
  • Stomatitis
  • Mouth ulceration
  • Cerebrovascular accident
  • Dysphemia
  • Withdrawal syndrome
  • Completed suicide
  • Suicide attempt
  • Hyperhidrosis
  • Sweating increased
  • Shock
  • Loss of consciousness
  • Thrombocytopenia
  • Tinnitus
  • Pollakiuria
  • Micturition urgency
  • Vertigo
  • Vomiting
  • Urinary retention
  • Akinesia
  • Stupor
  • Depressed level of consciousness
  • Hypokinesia
  • Cataract
  • Migraine
  • Cogwheel rigidity
  • Blood creatine phosphokinase increased
  • Tongue disorder
  • Tongue oedema
  • Ventricular extrasystoles
  • Galactorrhoea
  • Eye pain
  • Blood alkaline phosphatase increased
  • Skin discolouration
  • Dry skin
  • Uterine leiomyoma
  • Accommodation disorder
  • Photosensitivity reaction
  • Discomfort
  • Ill-defined disorder
  • Antisocial personality disorder
  • Antisocial behaviour
  • Asocial behaviour
  • Erectile dysfunction
  • Rectal haemorrhage
  • Dry eye
  • Rash maculo-papular
  • Bradycardia
  • Lymphadenopathy
  • Dementia
  • Coordination abnormal
  • Face oedema
  • Tardive dyskinesia
  • Blood uric acid increased
  • Uric acid high
  • Hyperuricaemia
  • Muscular weakness
  • Ejaculation disorder
  • Vaginal haemorrhage
  • Chills
  • Albuminuria
  • Angioedema
  • Arteritis
  • Atelectasis
  • Pneumothorax
  • Bursitis
  • Coma
  • Sudden death
  • Sudden death, cause unknown
  • Diabetic ketoacidosis
  • Enteritis
  • Eructation
  • Dermatitis
  • Rash
  • Glaucoma
  • Glossitis
  • Goitre
  • Gout
  • Cardiac failure
  • Hepatitis
  • Hiccups
  • Hirsutism
  • Hyperglycaemia
  • Hyperkalaemia
  • Hypernatraemia
  • Hypersensitivity
  • Hypertriglyceridaemia
  • Blood triglycerides increased
  • Intestinal obstruction
  • Jaundice
  • Keratitis
  • Ketosis
  • Mastitis
  • Miosis
  • Myopathy
  • Mydriasis
  • Neuralgia
  • Neutropenia
  • Nystagmus
  • Oliguria
  • Osteoporosis
  • Pancreatitis
  • Priapism
  • Pruritus
  • Pulmonary oedema
  • Pulmonary embolism
  • Rhabdomyolysis
  • Convulsion
  • Aphthous stomatitis
  • Stridor
  • Subarachnoid haemorrhage
  • Urticaria
  • Water intoxication
  • Normochromic normocytic anaemia
  • Encephalopathy
  • Deep vein thrombosis
  • Tongue discolouration
  • Lenticular pigmentation
  • Hepatic steatosis
  • Bone pain
  • Paraesthesia oral
  • Oesophageal ulcer
  • Urinary hesitation
  • Leukoderma
  • Hangover
  • Hepatobiliary disease
  • Anaphylactic shock
  • Anaphylactoid reaction
  • Neuropathy peripheral
  • Paralysis
  • Thrombocytosis
  • Embolism
  • Thromboembolism
  • Ileus
  • Diabetic hyperglycaemic coma
  • Diabetic coma
  • Breast enlargement
  • Hypoxia
  • Respiratory failure
  • Hypoventilation
  • Neuroleptic malignant syndrome
  • Blood bilirubin increased
  • Embolism venous
  • Dementia Alzheimer's type
  • Decreased appetite
  • Mental disorder
  • Breast disorder
  • Infection
  • Connective tissue disorder
  • Depression
  • Dyskinesia
  • Buccoglossal syndrome
  • Dysmenorrhoea
  • Extrapyramidal disorder
  • Fasting
  • Gastrointestinal disorder
  • Cardiac disorder
  • Body temperature decreased
  • Hypothermia
  • Immune system disorder
  • Mediastinal disorder
  • Muscle rigidity
  • Myoclonus
  • Drug withdrawal syndrome neonatal
  • Nervous system disorder
  • Obesity
  • Pregnancy
  • Sneezing
  • Torsade de pointes
  • Torticollis
  • Unintended pregnancy
  • Erythema
  • Urethral disorder
  • Urinary tract disorder
  • Angiopathy
  • Ventricular tachycardia
  • Viral infection
  • Weight decreased
  • Choreoathetosis
  • Hepatic failure
  • Ventricular arrhythmia
  • Apathy
  • Flat affect
  • Oculogyric crisis
  • Oculogyration
  • Lower respiratory tract infection
  • Injection site reaction
  • Injection site mass
  • Opisthotonus
  • Paranoia
  • Haemoglobin decreased
  • Malnutrition
  • Skin disorder
  • Ketoacidosis
  • Musculoskeletal pain
  • Cardiac fibrillation
  • Abdominal pain upper
  • Abdominal pain lower
  • Psychiatric symptom
  • Thinking abnormal
  • Mental disability
  • Hallucination, visual
  • Drug tolerance
  • Throat tightness
  • Blood pressure systolic decreased
  • Dependence
  • Induration
  • Viral upper respiratory tract infection
  • Platelet count decreased
  • Masked facies
  • Injection site induration
  • Haematocrit decreased
  • Infestation
  • Sleep disorder
  • Electrocardiogram change
  • Electrocardiogram QT prolonged
  • Thrombocytopenic purpura
  • Schizophrenia
  • Blood glucose increased
  • Blood albumin decreased
  • Blood creatine increased
  • Tooth infection
  • Respiratory tract infection viral
  • Liver disorder
  • Procedural pain
  • Mixed liver injury
  • Visual impairment

Indications

  • Agitation
  • Bipolar disorder
  • Bipolar I disorder
  • Childhood schizophrenia
  • Dementia
  • Depression
  • Extrapyramidal symptoms
  • Hyperlipidaemia
  • Increased activity
  • Major depression
  • Mania
  • Mania acute
  • Manic episode
  • Mental disorder
  • Movement disorder
  • Psychotic disorder
  • Schizoaffective disorder
  • Schizophrenia
  • Tension
  • Weight increased

Subjective effects []

0xea / Olanzapine []
Routes:
  • Oral
bonzi / Olanzapine []

 []

  • Australia: Olanzapine is a Schedule 4.
  • Brazil: Olanzapine is a C1.[3]
  • Canada: Olanzapine is Prescription only.
  • New Zealand: Olanzapine is Prescription only.
  • United Kingdom: Olanzapine is Prescription only.
  • United States: Olanzapine is Prescription only.[4]
  • European Union: Olanzapine is Prescription only.[5][6]

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 135398745, Olanzapine. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/135398745
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Olanzapine. UNII: N7U69T4SZR. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/N7U69T4SZR
  3. RDC Nº 784 – Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 31 March 2023. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
  4. Zyprexa- olanzapine tablet; Zyprexa Zydis- olanzapine tablet, orally disintegrating; Zyprexa intramuscular- olanzapine injection, powder, for solution. DailyMed. 13 December 2023. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d5051fbc-846b-4946-82df-341fb1216341
  5. Zyprexa EPAR. European Medicines Agency (EMA). 27 September 1996. https://www.ema.europa.eu/en/medicines/human/EPAR/zyprexa
  6. Zypadhera. European Medicines Agency (EMA). 19 November 2008. https://www.ema.europa.eu/en/medicines/human/EPAR/zypadhera

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 10:24:29
drugspromissing (no DrugsPRO reagent data)2026-11-20 10:24:25
erowidmissing (no Erowid substance of that name)2026-11-20 10:24:25
gsrsok2026-11-20 10:24:27
hmdbmissing (hmdb.ca refused automated access to HMDB0005012)2026-11-20 10:24:25
keggok2026-11-20 10:24:28
pubchemok2026-11-20 10:24:25
redditmissing (no r/tripreports posts mention it)2026-11-20 10:24:25
siderok2026-11-20 10:24:26
structureok2026-11-20 10:24:25
wikipediaok2026-11-20 10:24:26